Since last year, the pharmaceutical industry's online sales of prescription drugs will be officially banned. Although the State Food and Drug Administration has not yet announced the news, the pharmaceutical e-commerce platform has been waiting for it, and even has pre-recorded prescription drug information in the background of the website to prepare for the war, because once the gate is opened, the wolf will come. Not only Ali, Jingdong, Baidu, the most powerful Internet units representing BAT are quietly deploying medical e-commerce, and some powerful pharmaceutical companies are also eager to move...

Ali and the next city hand in hand, Guangyao Baiyun Mountain layout, medical prescriptions reversed

On the afternoon of January 13, Baiyunshan, a listed company under the GPHL Group, held a press conference and reached a strategic cooperation with Ali Health to jointly explore the O2O model of pharmaceutical retail, the reversal of pharmaceutical prescriptions, and the extension of modern pharmaceutical logistics under the background of new medical reform and mobile Internet. Services, smart pharmacies, future medicine and many other aspects. In addition, Guangyao Baiyunshan also announced a non-public offering (directed issuance) plan, which is planned to raise 10 billion yuan.

According to the plan, the total number of non-public issuance of A shares is no more than 41,946,100 shares, and the issue price is 23.84 yuan per share. The issue target is the company's controlling shareholder, Guangyao Group, Tianfu-Dingshengshengshi special account No. 66, asset management plan, Guangzhou Five specific targets, such as the State-owned Assets Development Holdings Co., Ltd., Guangzhou Guoshou Urban Development Industrial Investment Enterprise (Limited Partnership) and Shanghai Yunfeng Xinchuang Investment Management Co., Ltd., are all set up in cash, and the subscription amounts are approximately 3.495 billion yuan, 505 million yuan, 3 billion yuan, 2.5 billion yuan, 500 million yuan, the subscription period of the subscription shares is 36 months.

It is worth noting that Yunfeng Investment, one of the non-public issuance targets, is a special investment entity set up by Ma Yun, Chairman of Alibaba Group Chairman, and Shanghai Yunfeng Xinchuang Investment Management Co., Ltd., the founder of Juzhong Media. Yunfeng Fund was established in January 2010 and was jointly initiated by Ma Yun and Yu Feng, the current chairman of Yunfeng Fund. The fund currently holds shares in Alibaba, Alipay, Sogou, etc., and also invested in companies such as Damai.com, Huada Gene, Huayi Brothers Media, and Yuya Media.

In 2014, Internet giant Alibaba actively engaged in the layout. At the beginning of the year, Alibaba Group teamed up with Yunfeng Fund to conduct a strategic investment of US$170 million to CITIC 21st Century Co., Ltd. under CITIC Group, with a shareholding ratio of 54.3%, which promoted the development of Ali's medical and health fields. In October 2014, CITIC 21st Century Co., Ltd. changed its name to Ali Health Information Technology Co., Ltd. (abbreviated as Ali Health).

Talking about the marriage with Guangyao Baiyun Mountain, Ali Health CEO Wang Yaqing told reporters that the proportion of pharmaceutical e-commerce in the retail industry is still very low, or a big cake, the Internet and the traditional medicine industry can be very good. Go and cut the cake.

Li Chuyuan, chairman of Guangzhou Pharmaceutical Baiyunshan, believes that Ali and Yunfeng Fund’s “Ali Health” and Guangzhou Pharmaceutical Baiyunshan have reached a strategic cooperation intention, and will jointly explore the new medical reform and mobile Internet, the cross-border cooperation between the two sides. It will also provide new ideas and business models for the transformation of Guangzhou Pharmaceutical Baiyunshan into the Internet.

In addition, Guangyao Baiyunshan said that the total amount of non-public offerings will not exceed RMB 10 billion. After deducting the issuance expenses, all of them will be used to increase capital of Guangzhou Wang Lao Ji Da Health Industry Co., Ltd. and “Da Nan Pharmaceutical” R&D platform construction. The construction of the first phase of Da Nan Medicine's production base, the capital increase of Guangzhou Pharmaceutical Co., Ltd., the construction of information platform and other supplementary funds, of which 7.5 billion yuan invested in the three major businesses of “Da Nan Pharmaceutical”, “Great Health” and “Big Business” In the sector, the main investment direction of the other 2.5 billion yuan raised funds is the construction of the company's information platform (200 million yuan) and the supplementary company's working capital (2.3 billion yuan). Supplementary liquidity is mainly used to supplement working capital and integrate upstream and downstream assets of hospitals, medical enterprises, and Danan Pharmaceuticals.

Jingdong starts O2O layout

"At present, every family has entered thousands of prescription drug information, and also sent a licensed pharmacist for the online trial." Zhang Shengbing, general manager of Xiansheng Kangkang e-commerce, told reporters that there is currently no online prescription drug opening. New news, but most e-commerce platforms have already entered prescription drug information and indexed, while companies with offline chain pharmacies have also taken the lead in training licensed pharmacists, ready to review prescriptions online. “Users open the benefits in the hospital and upload them to the medical platform. The general pharmacist team of about 100 people is enough to deal with tens of thousands of transactions per day.”

According to a person familiar with the matter, Qi Lekang and Tmall Medicine have already completed the entry work, and even some platforms have selected more than 20 companies as pilot support for online prescription drugs. "Baidu has also set up a professional medical e-commerce team internally, and it is expected that strategic measures will be introduced soon."

The reporter noted that after obtaining the Internet Drug Trading Service A certificate, Jingdong has already promoted the “regional monopoly” investment model in the industry, that is, a large chain pharmacy corresponds to a city, and only customers in the corresponding area can purchase the The goods in the store. At present, there are 8 pharmaceutical chain enterprises such as Jingwei Pharmacy (Beijing), Fumei Pharmacy (Shanghai) and China United Pharmacy (Wuhan), which are located as exclusive partners, covering Beijing, Shanghai, Guangzhou, Hubei and Hebei. , Shandong and other key provinces and cities.

Embedding Cassettes

Embedding cassettes are processes used to embed material powders or other bulk structures to provide performance support or chemical protection. It can enhance the quality of the treatment of microorganisms or cells and avoid them be cutting trim. Embedding method is commonly used as immobilized devices for microorganisms, animal and plant cells.

Yingmed offers a wide selection of Embedding Cassettes with round or square hole.

Embedding Cassettes,White Embedding Cassettes,Plastic Embedding Cassettes,Embedding Cassette With Strip Holes

NINGBO YINGMED MEDICAL INSTRUMENTS CO.,LTD , https://www.chinayingmed.com